Back
PAR Technology 10K Form
Sell
43
PAR
PAR Technology
Last Price:
$62.45
Seasonality Move:
8.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | PAR/PAR Technology Quarterly |
2023-08-09 | 10Q | PAR/PAR Technology Quarterly |
2023-05-10 | 10Q | PAR/PAR Technology Quarterly |
2022-11-09 | 10Q | PAR/PAR Technology Quarterly |
2022-08-09 | 10Q | PAR/PAR Technology Quarterly |
2022-05-10 | 10Q | PAR/PAR Technology Quarterly |
Receive PAR News And Ratings
See the #1 stock for the next 7 days that we like better than PAR
PAR Financial Statistics
Sales & Book Value
Annual Sales: | $350M |
---|---|
Cash Flow: | $1.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $22.51 |
Price / Book: | 2.96 |
Profitability
EPS (TTM): | -0.15000 |
---|---|
Net Income (TTM): | $-5M |
Gross Margin: | $146.1M |
Return on Equity: | -0.83% |
Return on Assets: | -0.45% |
PAR Technology Earnings Forecast
Key PAR Technology Financial Ratios
-
The Gross Profit Margin over the past 41 years for PAR is 41.75%.
-
The Selling, General & Administrative Expenses for PAR have been equal to 43.03% of Gross Profit Margin.
-
The Research & Development expenses have been 19.22% of Revenue.
-
The Net Earning history of PAR is -1.42% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 24 years.
PAR Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Electronic Equipment, Instruments & Components |
Sector: | Information Technology |
Current Symbol: | PAR |
CUSIP: | 698884 |
Website: | partech.com |
Debt
Debt-to-Equity Ratio: | 0.42 |
---|---|
Current Ratio: | 1.95 |
Quick Ratio: | 1.51 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 221.55 |
PAR Technical Analysis vs Fundamental Analysis
Sell
43
PAR Technology (PAR)
is a Sell
Is PAR Technology a Buy or a Sell?
-
PAR Technology stock is rated a SellThe current PAR Technology [PAR] share price is $64.25. The Score for PAR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.